Effect of estrogen replacement therapy on endothelial function in peripheral resistance arteries in normotensive and hypertensive postmenopausal women

Hypertension

Volumn 37, Issue 2 II, 2001, Pages 651-657

  Higashi, Yukihito ^a   Sanada, Mitsuhiro ^a   Sasaki, Shota ^a   Nakagawa, Keigo ^a   Goto, Chikara ^a   Matsuura, Hideo ^a   Ohama, Koso ^a   Chayama, Kazuaki ^a   Oshima, Tetsuya ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Endothelium; Estrogen; Hypertension, essential; Nitroglycerin; Women

Indexed keywords

GLYCERYL TRINITRATE;

ADULT; AGED; BLOOD PRESSURE REGULATION; BODY WEIGHT; CARDIOVASCULAR RESPONSE; CONFERENCE PAPER; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; HYPEREMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PLETHYSMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; RISK BENEFIT ANALYSIS; SUBSTITUTION THERAPY; VASCULAR RESISTANCE;

EID: 0035092615     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.37.2.651     Document Type: Conference Paper

References (38)

1. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
2. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women
3. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/Progestin Replacement Study (HERS) Research Group
4. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study
5. Postmenopausal hormone therapy and mortality
6. Hormone therapy to prevent disease and prolong life in postmenopausal women
7. Estrogen improves endothelium-dependent. Flow-mediated vasodilation in postmenopausal women
8. Acute vascular effects of estrogen in postmenopausal women
9. 17β-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not with coronary heart disease
10. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: Blunted response in essential hypertension
11. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension
12. Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: Role of endothelium-derived nitric oxide
13. Imbalance of endothelium-derived relaxing and contracting factors
14. Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure (JNC-VI)
15. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge
16. Role of nitric oxide in reactive hyperemia in human forearm vessels
17. A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: A multicenter study
18. Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis
19. Hormone replacement therapy and serum angiotensin-converting enzyme activity in postmenopausal women
20. Hormone replacement therapy in postmenopausal women with essential hypertension increases circulating plasma levels of bradykinin
21. Estrogen, natriuretics peptides and the renin-angiotensin system
22. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall
23. Endothelium-dependent effects of converting enzyme inhibitors
24. Enhanced release of endothelium-derived relaxing factors by chronic increase in blood flow
25. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low density lipoproteins
26. Inactivation of endothelial-derived relaxing factor by oxidized lipoproteins
27. Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans
28. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production
29. Induction of calcium-dependent nitric oxide synthases by sex hormones
30. Estrogens increase transcription of the human endothelial NO synthase gene: Analysis of the transcription factors involved
31. Cardiovascular protection by oestrogen is partly mediated through modulation of autonomic nervous function
32. Guide to primary prevention of cardiovascular diseases: A statement for healthcare professionals from the task force on risk reduction
33. Evidence for oxidative stress in essential hypertension: Perspective for antioxidant therapy
34. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
35. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women
36. Hypertension, oral contraceptive agents and conjugated estrogens
37. Postmenopausal estrogen use and heart disease risk factors in the 1980s: Rancho Bernardo, Calif. revisited
38. A noninvasive method of reactive hyperemia is useful in assessing endothelial function instead of intra-arterial vasoactive agent infusion method in humans